Speeches Shim
Last updated: September 23, 2021
As of July 2021, the U.S. Government has allocated more than $36 million in new resources and two million doses of Pfizer-BioNTech vaccines to assist Peru in its emergency response to COVID-19. The aid continues a strong history of investing in Peru’s health care systems and long-term development, mainly through the U.S. Agency for International Development (USAID).
Ongoing U.S. Government-funded programs and partners are also adapting activities to respond to this unprecedented crisis. Over the last 20 years, U.S. assistance to Peru totals more than $3.5 billion, including $265 million in the health sector. Emergency assistance comes from the U.S. Agency for International Development (USAID), the Department of Defense Humanitarian Assistance Program, and the Department of State’s Emergency Refugee and Migration Assistance fund.
USAID partnership with Socios en Salud, the Peruvian affiliate of the U.S. non-profit organization Partners in Health, responds to COVID-19 in Peru.
This Alliance supports aggressive contact tracing, community mobilization, and systematic screening and isolation to prevent community spread of COVID-19. The $4.43 million investment from USAID mobilizes additional $1 million from Boston-based Partners in Health.
The United States is leading the global fight against COVID-19 to end the pandemic, stem and recover from the pandemic’s widespread secondary effects, take steps to mitigate future pandemic threats, and build back better the U.S. and global economy.
Countries across Sub-Saharan Africa (SSA)1 are experiencing a third wave of the coronavirus disease (COVID-19) pandemic, with the number of new weekly confirmed cases rising by more than 20 percent in 22 African countries during the second week of June, according to the UN World Health Organization (WHO); weekly confirmed cases rose by nearly 30 percent across the entire continent during the same period.
The number of coronavirus disease (COVID-19) cases have steadily decreased in Europe and Eurasia1 since April. However, despite falling infections, the health care systems in many central and eastern European countries continue to struggle to respond to the pandemic due to weak infrastructure and lack of access to COVID-19 vaccines, resulting in low vaccination rates compared to western European nations.
Comment
Make a general inquiry or suggest an improvement.